[Therapy of essential tremor with special reference to the use of beta-blockers].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001262:Atenolol / Q000627:therapeutic use; D002046:Bupranolol / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use; D014202:Tremor / Q000188:drug therapy* / Q000235:genetics
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D002046:Bupranolol; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol; D008790:Metoprolol
Therapie des essentiellen Tremors unter besonderer Berücksichtigung der Verwendung von Beta-Blockern.